Brain function improving agent
A novel agent useful for improving brain function is provided. The active ingredient in this agent is a Bifidobacterium breve and/or a Bifidobacterium breve -containing cultured material is provided.
1. A method for prevention, treatment, and/or improvement of symptoms or diseases resulting from reduced brain function in a subject, comprising a step of administering a Bifidobacterium breve and/or a cultured material comprising Bifidobacterium breve to the subject,
wherein said reduced brain function is a result of said subject having a condition selected from the group consisting of dementia, depression, schizophrenia, delirium, and combinations thereof, and
wherein the Bifidobacterium breve is Bifidobacterium breve MCC1274 (FERM BP-11175).
2. A method of prevention, treatment, and/or improvement of symptoms or diseases resulting from a reduced brain function in a subject, comprising a step of administering a food or beverage product comprising Bifidobacterium breve and/or a cultured material comprising Bifidobacterium breve to the subject,
wherein said reduced brain function is a result of said subject having a condition selected from the group consisting of dementia, depression, schizophrenia, delirium, and combinations thereof, and
wherein the Bifidobacterium breve is Bifidobacterium breve MCC1274 (FERM BP-11175).
3. The method of claim 1 , wherein said dementia is selected from the group consisting of Alzheimer's disease, dementia with Lewy bodies, frontotemporal dementia, cerebrovascular dementia, and combinations thereof.
4. The method of claim 2 , wherein said dementia is selected from the group consisting of Alzheimer's disease, dementia with Lewy bodies, frontotemporal dementia, cerebrovascular dementia, and combinations thereof.